CUE
Cue Biopharma·NASDAQ
--
--(--)
--
--(--)
CUE fundamentals
During Q4 2025, Cue Biopharma (CUE) reported revenue of 21.94M, a YoY change of 1292.26%. Net income was 1.58M, a YoY change of 116.69%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | 172.00K -- | 449.00K -- | 330.60K -- | 370.00K -- | 1.05M +513.37% | 984.00K +119.15% | 1.05M +217.40% | 900.00K +143.24% | 1.07M +1.90% | 704.00K -28.46% | 475.32K -54.70% | 1.55M +72.56% | 2.74M +154.79% | 2.40M +240.20% | 8.25M +1636.57% | 1.00M -35.61% | 26.00K -99.05% | 68.00K -97.16% | 151.00K -98.17% | 187.00K -81.30% | 1.38M +5215.38% | 2.10M +2988.24% | 1.82M +1105.96% | 1.72M +818.18% | 2.66M +92.33% | 3.34M +58.86% | 1.58M -13.45% | 421.00K -75.48% | 2.95M +11.14% | 2.15M -35.58% | 21.94M +1292.26% | 27.47M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | 172.00K -- | 449.00K -- | 330.60K -- | 370.00K -- | 1.05M +513.37% | 984.00K +119.15% | 1.05M +217.40% | 900.00K +143.24% | 1.07M +1.90% | 704.00K -28.46% | 475.32K -54.70% | 1.55M +72.56% | 2.74M +154.79% | 2.40M +240.20% | 8.25M +1636.57% | 1.00M -35.61% | 26.00K -99.05% | 68.00K -97.16% | 151.00K -98.17% | 187.00K -81.30% | 1.38M +5215.38% | 2.10M +2988.24% | 1.82M +1105.96% | 1.72M +818.18% | 2.66M +92.33% | 3.34M +58.86% | 1.58M -13.45% | 421.00K -75.48% | 2.95M +11.14% | 2.15M -35.58% | 21.94M +1292.26% | 27.47M -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | 172.00K -- | 449.00K -- | 330.60K -- | 370.00K -- | 1.05M +513.37% | 984.00K +119.15% | 1.05M +217.40% | 900.00K +143.24% | 1.07M +1.90% | 704.00K -28.46% | -2.68M -355.31% | 1.55M +72.56% | 2.74M +154.79% | 2.40M +240.20% | -6.69M -149.61% | 1.00M -35.61% | 26.00K -99.05% | 68.00K -97.16% | -1.09M +83.64% | 187.00K -81.30% | 1.38M +5215.38% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 3.35M -- | 4.41M -- | 5.03M -- | 10.44M -- | 7.52M +124.54% | 7.64M +73.22% | 13.21M +162.48% | 11.30M +8.22% | 11.80M +56.83% | 10.29M +34.56% | 8.08M -38.84% | 10.06M -10.91% | 13.89M +17.78% | 12.02M +16.83% | 10.84M +34.13% | 11.45M +13.76% | 14.07M +1.27% | 13.04M +8.53% | 15.41M +42.25% | 16.15M +41.03% | 15.24M +8.29% | 13.12M +0.57% | 11.10M -27.99% | 15.02M -7.00% | 13.57M -10.97% | 14.90M +13.59% | 13.52M +21.80% | 15.65M +4.24% | 14.38M +6.03% | 13.04M -12.47% | 12.15M -10.12% | 11.21M -28.39% | 12.72M -11.57% | 11.59M -11.13% | 9.74M -19.81% | 19.96M +78.11% | 54.02M -- |
Selling, General and Administrative Expenses | 889.00K -- | 996.00K -- | 1.03M -- | 1.42M -- | 1.70M +91.56% | 2.23M +123.90% | 2.90M +181.07% | 4.47M +215.19% | 3.44M +102.23% | 3.42M +53.32% | 2.78M -4.11% | 3.10M -30.71% | 3.99M +15.82% | 3.90M +14.01% | 3.32M +19.52% | 3.45M +11.16% | 4.25M +6.67% | 4.28M +9.80% | 4.13M +24.32% | 4.65M +34.83% | 5.16M +21.18% | 3.78M -11.64% | 3.53M -14.47% | 3.70M -20.29% | 4.18M -19.01% | 4.25M +12.35% | 3.65M +3.32% | 4.61M +24.43% | 4.19M +0.24% | 3.51M -17.37% | 2.87M -21.34% | 4.02M -12.76% | 4.17M -0.31% | 3.68M +4.78% | 4.94M +72.27% | 3.45M -14.15% | 16.24M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 14.65M -- | -- -- | -- -- | -- -- | 17.31M +18.12% | -- -- | -- -- | -- -- | 16.17M -6.57% | -- -- | -- -- | 3.65M -- | 4.61M -71.49% | 4.19M -- | 3.51M -- | 2.87M -21.34% | 4.02M -12.76% | 4.17M -0.31% | 3.68M +4.78% | 4.94M +72.27% | 3.45M -14.15% | 16.24M -- |
Research and Development Expenses | 2.46M -- | 3.42M -- | 4.00M -- | 9.02M -- | 5.82M +136.45% | 5.41M +58.44% | 10.31M +157.70% | 6.82M -24.35% | 8.35M +43.55% | 6.87M +26.84% | 5.30M -48.59% | 6.96M +2.07% | 9.91M +18.59% | 8.12M +18.23% | 7.52M +41.78% | 8.00M +14.92% | 9.82M -0.91% | 8.76M +7.92% | 11.29M +50.17% | 11.50M +43.69% | 10.08M +2.71% | 9.59M +9.47% | 7.57M -32.93% | 11.33M -1.47% | 9.39M -6.85% | 10.65M +11.03% | 9.87M +30.42% | 10.89M -3.93% | 10.20M +8.60% | 9.53M -10.52% | 9.38M -4.99% | 7.18M -34.01% | 8.55M -16.20% | 7.91M -17.00% | 4.75M -49.32% | 16.53M +130.12% | 37.74M -- |
Loss on Disposal of Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -277.00K -- | -- -- | -- -- | 0 -- | 157.00K +156.68% | -- -- | -- -- | -97.00K -- | 4.00K -97.45% | -- -- | -- -- | 51.00K +152.58% | -20.00K -600.00% | -- -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -258.00K -- | -- -- | 258.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -3.35M -- | -4.41M -- | -5.03M -- | -10.44M -- | -7.52M -124.54% | -7.47M -69.32% | -12.76M -153.56% | -10.97M -5.06% | -11.43M -51.91% | -9.23M -23.54% | -7.09M +44.40% | -9.02M +17.79% | -12.99M -13.72% | -10.94M -18.54% | -10.13M -42.81% | -10.97M -21.73% | -12.52M +3.67% | -10.30M +5.84% | -13.02M -28.50% | -7.89M +28.08% | -14.24M -13.74% | -13.09M -27.05% | -11.03M +15.26% | -14.87M -88.34% | -13.38M +6.03% | -13.52M -3.26% | -11.42M -3.52% | -13.83M +6.96% | -12.67M +5.32% | -10.38M +23.19% | -8.81M +22.80% | -9.63M +30.36% | -12.30M +2.91% | -8.63M +16.84% | -7.59M +13.84% | 1.98M +120.53% | -26.55M -- |
Non-Operating Income (Loss) | -- -- | -- -- | -- -- | 35 -- | -1.00K -- | 172.00K -- | 200.00K -- | 170.34K +486600.00% | 160.00K +16100.00% | 122.00K -29.07% | 104.00K -48.00% | 96.79K -43.18% | 177.00K +10.63% | 109.00K -10.66% | 100.00K -3.85% | 77.91K -19.50% | 13.00K -92.66% | 24.00K -77.98% | 25.00K -75.00% | 3.90K -95.00% | -17.00K -230.77% | -118.00K -591.67% | 76.00K +204.00% | 274.00K +6929.25% | 271.00K +1694.12% | 332.00K +381.36% | 414.00K +444.74% | 398.00K +45.26% | 321.00K +18.45% | 212.00K -36.14% | 155.00K -62.56% | 137.00K -65.58% | 42.00K -86.92% | 153.00K -27.83% | 147.00K -5.16% | 107.00K -21.90% | 449.00K -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -1.00K -- | 2.00K -- | 98.00K -- | 66.34K -- | 46.00K +4700.00% | 26.00K +1200.00% | 5.00K -94.90% | -77.00K -216.07% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -35 -- | -- -- | -170.00K -- | -102.00K -- | -104.01K -297065.71% | -114.00K -- | -96.00K +43.53% | -99.00K +2.94% | -173.79K -67.09% | -177.00K -55.26% | -109.00K -13.54% | -100.00K -1.01% | -77.91K +55.17% | -13.00K +92.66% | -24.00K +77.98% | -25.00K +75.00% | -3.90K +95.00% | 17.00K +230.77% | 118.00K +591.67% | -76.00K -204.00% | -274.00K -6929.25% | -271.00K -1694.12% | -332.00K -381.36% | -414.00K -444.74% | -398.00K -45.26% | -321.00K -18.45% | -212.00K +36.14% | -155.00K +62.56% | -137.00K +65.58% | -42.00K +86.92% | -153.00K +27.83% | -147.00K +5.16% | -107.00K +21.90% | -449.00K -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 25.00K -- | 206.00K -- | 124.00K -- | 358.00K -- | 370.00K +1380.00% | 232.00K +12.62% | 286.00K +130.65% | 507.00K +41.62% | 241.00K -34.86% | 215.00K -7.33% | 188.00K -34.27% | 153.00K -69.82% | 128.00K -46.89% | 45.00K -79.07% | 75.00K -60.11% | 51.00K -66.67% | 299.00K -- |
Interest Income | -- -- | -- -- | -- -- | 35 -- | -- -- | 170.00K -- | 102.00K -- | 104.01K +297065.71% | 114.00K -- | 96.00K -43.53% | 99.00K -2.94% | 173.79K +67.09% | 177.00K +55.26% | 109.00K +13.54% | 100.00K +1.01% | -386.00K -322.11% | 13.00K -92.66% | 24.00K -77.98% | 25.00K -75.00% | 3.90K +101.01% | 8.00K -38.46% | 88.00K +266.67% | 200.00K +700.00% | 632.00K +16113.44% | 641.00K +7912.50% | 564.00K +540.91% | 700.00K +250.00% | 905.00K +43.20% | 562.00K -12.32% | 427.00K -24.29% | 343.00K -51.00% | 290.00K -67.96% | 170.00K -69.75% | 198.00K -53.63% | 222.00K -35.28% | 158.00K -45.52% | 748.00K -- |
Pretax Income From Continuing Operations | -3.35M -- | -4.41M -- | -5.03M -- | -10.44M -- | -7.52M -124.57% | -7.30M -65.42% | -12.56M -149.58% | -10.80M -3.42% | -11.27M -49.77% | -9.11M -24.78% | -6.99M +44.34% | -8.92M +17.39% | -12.82M -13.77% | -10.83M -18.93% | -10.03M -43.51% | -10.90M -22.18% | -12.51M +2.44% | -10.28M +5.11% | -12.99M -29.53% | -7.89M +27.60% | -14.26M -13.99% | -13.21M -28.49% | -10.96M +15.69% | -14.59M -84.96% | -13.11M +8.04% | -13.19M +0.17% | -11.01M -0.46% | -13.43M +7.94% | -12.35M +5.81% | -10.17M +22.86% | -8.66M +21.31% | -9.50M +29.31% | -12.26M +0.73% | -8.48M +16.61% | -7.45M +14.00% | 2.08M +121.96% | -26.10M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 825.00K -- | -- -- | 413.00K -- | -- -- | -500 -100.06% | -- -- | -- -- | -- -- | 206.25K +41350.00% | -- -- | -- -- | -- -- | 495.00K +140.00% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 500.00K -- | -- -- |
Other Items Before Net Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -3.35M -- | -4.41M -- | -5.03M -- | -10.44M -- | -7.52M -124.57% | -7.30M -65.42% | -12.56M -149.58% | -11.62M -11.33% | -11.27M -49.77% | -9.52M -30.44% | -6.99M +44.34% | -8.92M +23.27% | -12.82M -13.77% | -10.83M -13.77% | -10.03M -43.51% | -11.10M -24.51% | -12.51M +2.44% | -10.28M +5.11% | -12.99M -29.53% | -8.38M +24.49% | -14.26M -13.99% | -13.21M -28.49% | -10.96M +15.69% | -14.59M -74.04% | -13.11M +8.04% | -13.19M +0.17% | -11.01M -0.46% | -13.43M +7.94% | -12.35M +5.81% | -10.17M +22.86% | -8.66M +21.31% | -9.50M +29.31% | -12.26M +0.73% | -8.48M +16.61% | -7.45M +14.00% | 1.58M +116.69% | -26.60M -- |
Net Income Attributable to Owners of the Company | -3.35M -- | -4.41M -- | -5.03M -- | -10.44M -- | -7.52M -124.57% | -7.30M -65.42% | -12.56M -149.58% | -11.62M -11.33% | -11.27M -49.77% | -9.52M -30.44% | -6.99M +44.34% | -8.92M +23.27% | -12.82M -13.77% | -10.83M -13.77% | -10.03M -43.51% | -11.10M -24.51% | -12.51M +2.44% | -10.28M +5.11% | -12.99M -29.53% | -8.38M +24.49% | -14.26M -13.99% | -13.21M -28.49% | -10.96M +15.69% | -14.59M -74.04% | -13.11M +8.04% | -13.19M +0.17% | -11.01M -0.46% | -13.43M +7.94% | -12.35M +5.81% | -10.17M +22.86% | -8.66M +21.31% | -9.50M +29.31% | -12.26M +0.73% | -8.48M +16.61% | -7.45M +14.00% | 1.58M +116.69% | -26.60M -- |
Other Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -1.00K -- | 1.00K -- | -- -- |
Net Income Attributable to Common Stockholders | -3.35M -- | -4.41M -- | -5.03M -- | -10.44M -- | -7.52M -124.57% | -7.30M -65.42% | -12.56M -149.58% | -11.62M -11.33% | -11.27M -49.77% | -9.52M -30.44% | -6.99M +44.34% | -8.92M +23.27% | -12.82M -13.77% | -10.83M -13.77% | -10.03M -43.51% | -11.10M -24.51% | -12.51M +2.44% | -10.28M +5.11% | -12.99M -29.53% | -8.38M +24.49% | -14.26M -13.99% | -13.21M -28.49% | -10.96M +15.69% | -14.59M -74.04% | -13.11M +8.04% | -13.19M +0.17% | -11.01M -0.46% | -13.43M +7.94% | -12.35M +5.81% | -10.17M +22.86% | -8.66M +21.31% | -9.50M +29.31% | -12.26M +0.73% | -8.48M +16.61% | -7.45M +14.01% | 1.58M +116.68% | -26.60M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -20.00K -- | 9.04K -- | -3.00K -- | 3.00K -- | -- -- | -10.36K -214.61% | 259.00K +8733.33% | -94.00K -3233.33% | 83.00K -- | -64.55K -522.87% | -7.00K -102.70% | -- -- | -- -- | -131 +99.80% | -- -- | -- -- | -92.00K -- | -4.00K -2953.44% | 57.00K -- | 34.00K -- | 5.00K +105.43% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -3.35M -- | -4.41M -- | -5.03M -- | -10.44M -- | -7.52M -124.57% | -7.30M -65.42% | -12.58M -149.98% | -11.61M -11.24% | -11.27M -49.81% | -9.52M -30.40% | -6.99M +44.43% | -8.93M +23.12% | -12.56M -11.44% | -10.93M -14.79% | -9.95M -42.32% | -11.17M -25.09% | -12.51M +0.37% | -10.28M +5.93% | -12.99M -30.61% | -8.38M +24.92% | -14.26M -13.93% | -13.21M -28.49% | -11.05M +14.98% | -14.60M -74.09% | -13.05M +8.44% | -13.15M +0.43% | -11.00M +0.43% | -13.43M +7.96% | -12.35M +5.40% | -10.17M +22.66% | -8.66M +21.27% | 31.18M +332.08% | -12.26M +0.73% | -8.48M +16.61% | -7.45M +14.00% | 28.19M -9.59% | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -3.35M -- | -4.41M -- | -5.03M -- | -10.44M -- | -7.52M -124.57% | -7.30M -65.42% | -12.58M -149.98% | -11.61M -11.24% | -11.27M -49.81% | -9.52M -30.40% | -6.99M +44.43% | -8.93M +23.12% | -12.56M -11.44% | -10.93M -14.79% | -9.95M -42.32% | -11.17M -25.09% | -12.51M +0.37% | -10.28M +5.93% | -12.99M -30.61% | -8.38M +24.92% | -14.26M -13.93% | -13.21M -28.49% | -11.05M +14.98% | -14.60M -74.09% | -13.05M +8.44% | -13.15M +0.43% | -11.00M +0.43% | -13.43M +7.96% | -12.35M +5.40% | -10.17M +22.66% | -8.66M +21.27% | 31.18M +332.08% | -12.26M +0.73% | -8.48M +16.61% | -7.45M +14.00% | 28.19M -9.59% | -- -- |
Basic EPS | -0.31 -- | -0.41 -- | -0.47 -- | -0.54 -- | -0.37 -19.35% | -0.36 +12.20% | -0.62 -31.91% | -0.56 -3.70% | -0.54 -45.95% | -0.46 -27.78% | -0.31 +50.00% | -0.34 +39.29% | -0.48 +11.11% | -0.38 +17.39% | -0.34 -9.68% | -0.37 -8.82% | -0.41 +14.58% | -0.33 +13.16% | -0.41 -20.59% | -0.26 +29.73% | -0.44 -7.32% | -0.37 -12.12% | -0.31 +24.39% | -0.34 -30.77% | -0.29 +34.09% | -0.29 +21.62% | -0.24 +22.58% | -0.28 +17.65% | -0.25 +13.79% | -0.2 +31.03% | -0.17 +29.17% | -0.15 +46.43% | -0.17 +32.00% | -0.09 +55.00% | -0.07 +58.82% | 0.02 +113.33% | -0.31 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.24 -- | -- -- | -0.25 -- | -0.2 -- | -0.17 +29.17% | -- -- | -0.17 +32.00% | -0.09 +55.00% | -0.07 +58.82% | -- -- | -- -- |
Diluted EPS | -0.31 -- | -0.41 -- | -0.47 -- | -- -- | -0.37 -19.35% | -0.36 +12.20% | -0.62 -31.91% | -- -- | -0.54 -45.95% | -0.46 -27.78% | -0.31 +50.00% | -- -- | -0.48 +11.11% | -0.38 +17.39% | -0.34 -9.68% | -- -- | -0.41 +14.58% | -0.33 +13.16% | -0.41 -20.59% | -- -- | -0.44 -7.32% | -0.37 -12.12% | -0.31 +24.39% | -- -- | -0.29 +34.09% | -0.29 +21.62% | -0.24 +22.58% | -- -- | -0.25 +13.79% | -0.2 +31.03% | -0.17 +29.17% | -- -- | -0.17 +32.00% | -0.09 +55.00% | -0.07 +58.82% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.24 -- | -- -- | -0.25 -- | -0.2 -- | -0.17 +29.17% | -- -- | -0.17 +32.00% | -0.09 +55.00% | -0.07 +58.82% | -- -- | -- -- |
You can ask Aime
What were the key takeaways from Cue Biopharma's earnings call?What is Cue Biopharma's gross profit margin?What guidance did Cue Biopharma's management provide for the next earnings period?What is the revenue and EPS growth rate for Cue Biopharma year over year?What does Cue Biopharma do and what are its main business segments?What factors drove the changes in Cue Biopharma's revenue and profit?What were the key takeaways from Cue Biopharma’s earnings call?Did Cue Biopharma beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
